{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:41:06Z","timestamp":1791096066294,"version":"4.1.0"},"reference-count":62,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T00:00:00Z","timestamp":1326326400000},"content-version":"vor","delay-in-days":437,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2010,11]]},"abstract":"<jats:p>\n                    Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke\u2010like episodes (MELAS) syndrome is a rare neurodegenerative disease caused by the decreased ability of cells to produce sufficient energy in the form of adenosine 5\u2032\u2010triphosphate. Although it is one of the most common maternally inherited mitochondrial disorders, its exact incidence is unknown. Caused most frequently by an A\u2010to\u2010G point mutation at the 3243 position in the mitochondrial DNA, MELAS syndrome has a broad range of clinical manifestations and a highly variable course. The classic neurologic characteristics include encephalopathy, seizures, and stroke\u2010like episodes. In addition to its neurologic manifestations, MELAS syndrome exhibits multisystem effects including cardiac conduction defects, diabetes mellitus, short stature, myopathy, and gastrointestinal disturbances. Unfortunately, no consensus guidelines outlining standard drug regimens exist for this syndrome. Many of the accepted therapies used in treating MELAS syndrome have been identified through a small number of clinical trials or isolated case reports. Currently, the drugs most often used include antioxidants and various vitamins aimed at minimizing the demands on the mitochondria and supporting and maximizing their function. Some of the most frequently prescribed agents include coenzyme Q\n                    <jats:sub>10<\/jats:sub>\n                    , L\u2010arginine, B vitamins, and levocarnitine. Although articles describing MELAS syndrome are available, few specifically target education for clinical pharmacists. This article will provide pharmacists with a practical resource to enhance their understanding of MELAS syndrome in order to provide safe and effective pharmaceutical care.\n                  <\/jats:p>","DOI":"10.1592\/phco.30.11.1179","type":"journal-article","created":{"date-parts":[[2010,10,25]],"date-time":"2010-10-25T14:25:19Z","timestamp":1288016719000},"page":"1179-1196","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Treatment Options for Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke\u2010Like Episodes (MELAS) Syndrome"],"prefix":"10.1002","volume":"30","author":[{"given":"Kristin M.","family":"Santa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,1,12]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1444.011"},{"key":"e_1_2_1_3_2","first-page":"404","volume-title":"Diseases caused by genetic defects of mitochondria","author":"Braunwald E.","year":"2001"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6714-3_1"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100720070002"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01376517-199510000-00007"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200620060-00002"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","unstructured":"NainiA. KaufmannP. ShanskeS. et al.Hypocitrullinemia in patients with MELAS: an insight into the \u201cMELAS paradox.Neurol Sci2005;229\u2013230:187\u201393.","DOI":"10.1016\/j.jns.2004.11.026"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0b013e3180334cb0"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00127893-200209000-00003"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/301959"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNN.0b013e3180335faf"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/088307389400900102"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.11.1625"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000308940.38092.74"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.4.1013"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000120557.83907.A8"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000091888.26232.FE"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.5.751"},{"key":"e_1_2_1_20_2","first-page":"197","article-title":"Management of mitochondrial disease on an intensive care unit","volume":"88","author":"Howard RS","year":"1995","journal-title":"QJM"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(03)00097-X"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199404073301403"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03341.x"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000220197.36849.1e"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1320460504"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430313"},{"key":"e_1_2_1_27_2","first-page":"625","article-title":"Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA(Leu) gene (m.3243A<G)","volume":"64","author":"Sproule DM","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-0981-8"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02761.x"},{"key":"e_1_2_1_30_2","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"1","author":"Salpeter S.","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8223(03)00476-0"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-009-0046-0"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02789.x"},{"key":"e_1_2_1_34_2","first-page":"973","article-title":"Mitochondrial hepatopathies","volume":"53","author":"Bandyopadhyay SK","year":"2005","journal-title":"J Assoc Physicians India"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004193221602"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03012149"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)90004-3"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-006-9039-9"},{"key":"e_1_2_1_39_2","first-page":"1989","article-title":"Possible biochemical mechanism of the toxic effects of barbiturates","volume":"43","author":"Rantikova LA","year":"1978","journal-title":"Biokhimiia"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1159\/000101287"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(83)80842-4"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.2.634"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-17948"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2009.11.005"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.5.884"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1159\/000117445"},{"key":"e_1_2_1_47_2","article-title":"Treatment for mitochondrial disorders","volume":"1","author":"Chinnery P.","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000151976.60624.01"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2006.11.006"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.11.2147"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.8.1275"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6486-9_10"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1159\/000013406"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20688"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.2.583"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100720070015"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(90)90212-3"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000196641.05913.27"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0387-7604(97)00573-1"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1097\/00127893-200209000-00004"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230312"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.43.427"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.30.11.1179","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.30.11.1179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:31:13Z","timestamp":1761067873000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.30.11.1179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["10.1592\/phco.30.11.1179"],"URL":"https:\/\/doi.org\/10.1592\/phco.30.11.1179","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"2012-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}